CSL Valuation
| CSLLY Stock | USD 88.17 0.01 0.01% |
At this time, the firm appears to be fairly valued. CSL shows a prevailing Real Value of $87.29 per share. The current price of the firm is $88.17. Our model approximates the value of CSL from analyzing the firm fundamentals such as Profit Margin of 0.18 %, return on equity of 0.13, and Operating Margin of 0.25 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that CSL's price fluctuation is very steady at this time. Calculation of the real value of CSL is based on 3 months time horizon. Increasing CSL's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since CSL is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CSL Pink Sheet. However, CSL's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 88.17 | Real 87.29 | Hype 88.17 | Naive 90.38 |
The intrinsic value of CSL's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence CSL's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of CSL helps investors to forecast how CSL pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CSL more accurately as focusing exclusively on CSL's fundamentals will not take into account other important factors: CSL Total Value Analysis
CSL is currently expected to have takeover price of 96.65 B with market capitalization of 103.45 B, debt of 3.86 B, and cash on hands of 10.44 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the CSL fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
96.65 B | 103.45 B | 3.86 B | 10.44 B |
CSL Investor Information
The company last dividend was issued on the 2nd of September 2022. CSL had 3:1 split on the 24th of October 2007. CSL is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.CSL Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CSL has an asset utilization ratio of 37.02 percent. This suggests that the Company is making $0.37 for each dollar of assets. An increasing asset utilization means that CSL is more efficient with each dollar of assets it utilizes for everyday operations.CSL Ownership Allocation
CSL holds a total of 964.43 Million outstanding shares. Almost 99.93 percent of CSL outstanding shares are held by general public with 0.07 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.CSL Profitability Analysis
The company reported the revenue of 10.49 B. Net Income was 2.25 B with profit before overhead, payroll, taxes, and interest of 5.73 B.About CSL Valuation
Our relative valuation model uses a comparative analysis of CSL. We calculate exposure to CSL's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CSL's related companies.CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. Csl operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 30000 people.
8 Steps to conduct CSL's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates CSL's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct CSL's valuation analysis, follow these 8 steps:- Gather financial information: Obtain CSL's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine CSL's revenue streams: Identify CSL's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research CSL's industry and market trends, including the size of the market, growth rate, and competition.
- Establish CSL's growth potential: Evaluate CSL's management, business model, and growth potential.
- Determine CSL's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate CSL's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
CSL Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 939.5 M | |
| Quarterly Earnings Growth Y O Y | -0.125 | |
| Forward Price Earnings | 44.0529 | |
| Retained Earnings | 13.5 B |
Additional Tools for CSL Pink Sheet Analysis
When running CSL's price analysis, check to measure CSL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CSL is operating at the current time. Most of CSL's value examination focuses on studying past and present price action to predict the probability of CSL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CSL's price. Additionally, you may evaluate how the addition of CSL to your portfolios can decrease your overall portfolio volatility.